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ABSTRACT  
Microbial keratitis is a severe, sight threatening condition caused by various pathogens. 
Eyedrops are the standard delivery modality for treating these disorders; however, blinking 
reflex, elevated tear production and nasolacrimal drainage eliminate much of the instilled 
dose within a few seconds. Therefore, eye drops must be applied repeatedly for prolonged 
periods. The present study aimed to probe more effective ocular delivery of chlorhexidine 
based upon drug-loaded hydrogel contact lenses and β-cyclodextrin (β-CD), whilst also 
determining the effect of constant irrigation with simulated tear fluid (STF) in in vitro 
experiments. 
Chlorhexidine digluconate (as 0.2 and 2.0% solution, β-CD inclusion complexes and loaded 
hydrogel contact lenses) were applied to enucleated porcine eyes as single or multiple 10 µL 
doses, or as drug-loaded contact lenses, with and without β-CD. The corneas were then 
excised and drug extracted quantified by HPLC. The effect of constant irrigation by STF was 
evaluated to test the effect of increased tear production on corneal delivery. Potential 
antimicrobial activity of delivered drug was also assessed. 
Results showed that drug-loaded contact lenses delivered the greatest amount of 
chlorhexidine into the cornea over a 24 h period, whilst the eyedrop solution comparator 
delivered the least. The β-CD significantly enhanced chlorhexidine delivery to the cornea 
from eyedrop solution, although contact lenses loaded with chlorhexidine-β-CD failed to 
enhance delivery. β-CD within the hydrogel matrix impeded drug release. Constant irrigation 
with STF significantly reduced the amount of drug delivered to the cornea in all cases. 
Chlorhexidine retained antimicrobial activity in all delivery methods. 
Hydrogel contact lenses loaded with chlorhexidine delivered significantly higher levels to the 
cornea compared to eyedrops, either multiple hourly doses or a single dose. They also offer 
reduced application, in particular to a non-ulcerated corneal infection. Finally, the importance 
of fully accounting for tear production in in vitro ocular delivery experiments was 
highlighted. 
 
KEYWORDS Antimicrobial, β-cyclodextrin, chlorhexidine, contact lens, cornea, E. coli, 
hydrogel, keratitis, NMR. 
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1. Introduction 
Microbial keratitis (MK) is a condition in which the cornea becomes inflamed due to the 
presence of pathogens and, if not promptly treated, can cause permanent vision damage or 
even total blindness.1 It is a particular problem in low and middle-income countries, where it 
has been reported as the second most common cause of corneal blindness2, for example, in 
sub-Saharan Africa corneal scarring, mostly from keratitis, accounts for 15% of monocular 
blindness; and is also problematic in other animals.3 MK is usually caused by infection with 
pathogenic microorganisms gaining access to the stroma following epithelial trauma such as 
abrasions or improper contact lens use, where they subsequently proliferate, triggering a host 
inflammatory response and further symptoms including severe pain, blurred vision, 
photosensitivity, increased tear production and typically ulceration.4,5 Invasive 
microorganisms can include bacteria, viruses, fungi and protozoans in particular 
Acanthamoeba. Patients presenting with bacterial keratitis typically respond well to current 
treatments, although cases caused by fungi (including Fusarium and Aspergillus) and 
Acanthamoeba, tend to have poorer responses. The reasons for this are multifactorial but can 
include ineffectual drug delivery systems.5,6 Therapeutic surgical intervention, including 
penetrating keratoplasty is required in the severest cases which are unresponsive to drug 
therapy.1,7-9  
Chlorhexidine digluconate (Figure 1) is a widely used broad-spectrum microbicidal 
agent10-12 that has previously been proposed for treating fungal13 and Acanthamoeba 
keratitis.14-16 Chlorhexidine can attach to the cellular membranes of microbes and disrupt 
their integrity, penetrate cells and cause leakage of their components and ultimately cell 
death.17,18 Typically, current treatments are delivered in the form of topically applied 
conventional eyedrops, which have the advantage of being inexpensive and easily 
administered. However, whilst the cornea may appear to be easily accessible for treatment, 
delivery into this tissue is particularly challenging with numerous physicochemical barriers 
hindering drug penetration. Additionally, other factors such as elevated tear production, 
blinking reflex and nasolacrimal drainage work together to significantly reduce ocular 
residence time of a drug, such that only 1 to 7 % of the instilled drug reaching the stroma. In 
practical terms, eye drops must thus be applied frequently, usually initially hourly or half 
hourly for several days, and then gradually tailed off over several weeks to maintain a 
therapeutic concentration in the cornea. 19-21 Such demanding administration regimens can 
result in poor patient compliance and discontinuation of treatment, whilst also potentially 
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increasing the risk of toxicity.22,23 Additionally, nasolacrimal drainage can result in systemic 
absorption of the drug, potentially leading to adverse side effects.24 For the relatively low 
amount of drug that remains, penetration of the corneal epithelium is challenging due to the 
diffusional barriers25 and due to low concentration. As is the case for most membranes, drug 
permeation across intact corneal barriers is governed by Fick’s first law: 




Where J is flux [cm-2/s], D is diffusivity [cm2/s] and δC/δx is the concentration gradient [cm-
4]. The flux of a molecule across a membrane is thus enhanced when: 1. the concentration 
gradient is high (Figure 2), achievable if the dose can be retained at the cornea surface,26 
and/or 2. the membrane is modulated such that its diffusivity is increased. These two 
parameters may also be used cooperatively to achieve even greater rates of drug delivery. 
Generally used to increase the concentration of a poorly water-soluble drug in an 
aqueous solution, cyclodextrins (CD) are cyclic oligosaccharides composed of D-glucose 
units, linked by α-1,4-glucosidic linkages (Figure 1). This is exploited in ocular drug 
delivery, as drug-cyclodextrin inclusion complexes have improved solubility, reduce 
irritation and enhance drug permeability.27 Chlorhexidine has been shown to form inclusion 
complexes with β-cyclodextrin (β-CD)28,29 resulting in enhanced uptake and release 
properties from polymeric nanogels.30 Drug-loaded soft hydrogel contact lenses are an 
attractive and convenient ocular drug delivery approach. Consisting of a three-dimensional 
polymer network, contact lenses possess the ability to absorb drug solutions and retain them 
in their hydrogel matrix.31 By attaching to the tear film over the cornea, they increase the 
ocular residence time of the incorporated medication and, thus, allow greater opportunity for 
drug release and instillation.26 Sustained, controlled release of the entrapped drug is also 
achieved via passive diffusion out of the hydrogel matrix of lenses and into the cornea, as 
according to Fick’s diffusion law, telling us that the greater the concentration gradient, the 
great the drug flux rate (Figure 2). This is important as microbial infiltrates are generally 
located within the aqueous environment of the stroma, located between the epithelial 
membrane and Bowman’s layer of the cornea. Also, the extended residence time of contact 
lenses can circumvent the frequent dosing issues associated with eyedrops and produce 
higher drug penetration.32 
Furthermore, challenges arise in the field of ocular formulation development when 
considering how to test formulations. In vitro or ex vivo experiments using excised porcine or 
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bovine eyes are typical, yet such experiments need to be representative of in vivo ocular 
delivery. When used in static model, tear production and blinking are typically not accounted 
for. An additional aim of this work was therefore to investigate the effect of constant drop-
wise irrigation of the eye with simulated tear fluid (STF) on ocular drug delivery. We then 
used this model to probe the enhanced ocular delivery of chlorhexidine into porcine corneas 
in vitro using a combination of β-CD and hydrogel contact lenses for enhanced delivery of 






Chlorhexidine digluconate (20 % solution), LB agar, phosphate buffer saline (PBS) tablets, 
NaCl, NaHCO3, CaCl2 and β-cyclodextrin (β-CD) were purchased from Sigma-Aldrich, 
Gillingham, UK. KCl was purchased from Fisher Scientific, Loughborough, UK. Freshly 
excised porcine eyes were obtained from a local abattoir on the day of slaughter and kept in a 
refrigerator overnight for use the next day.  ClaritiTM 1 Day silicone hydrogel contact lenses 
were a gift from Cardiff University Eye Clinic. Escherichia coli, National Collection of Type 
Cultures (NCTC) strain reference 10418 was purchased from NCTC, Salisbury, UK. 
 
2.2 Preparation of solutions and drug loaded contact lenses  
Chlorhexidine digluconate, 20 %, was diluted with deionised water to obtain 0.2 %, 2.0 % 
solutions – lower levels were not evaluated in this work. To test the effect of including 
cyclodextrin to the eyedrop solution, 30 mg/mL β-CD was added to 2.0 % chlorhexidine and 
stirred overnight at 2-4 ºC. ClaritiTM 1-day silicone hydrogel contact lenses were soaked in 
10 mL deionized water for 4 h on a rocking plate to remove storage medium, before being 
immersed in test solutions overnight using a tube rotator. Prior to use the lenses were 
removed from solution, lightly blotted and weighed. 
 
2.3 Preparation and use of simulated tear fluid (STF)  
As we were investigating dilution/wash-out effects an electrolyte-only STF was used, 
prepared based upon a previously reported method.33 In a glass beaker 0.68 g NaCl, 0.22 g 
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NaHCO3, 0.008 g CaCl2, 0.14 g KCl were dissolved in 1L deionized water. STF was 
delivered to the corneas of excised porcine eyes using capillary tubing and a gravity-fed 
reservoir at a continuous and reproducible rate of 100 μL/min, maintaining an evenly 
distributed artificial tear film on in vitro eyes for the duration of the experiments. To directly 
test the effect of STF, an equal number of eyes received constant irrigation, the other half 
remained non-irrigated.  
 
2.4 In vitro corneal penetration  
Enucleated porcine eyes were checked for abrasions with a magnifying glass, before being 
trimmed of excess tissue and placed cornea uppermost into the wells of a 6-well plate; each 
well containing 2 mL PBS at the bottom of the well to limit dehydration with corneas well 
above this level. The plate with eyeballs was placed in a water bath set at 37 ºC before being 
dosed with drug treatment. Using a calibrated pipette, 10 µL aliquots of eyedrop solution 
were applied – an amount comparable to the residual volume remaining after delivery with 
commercial eyedrops (around 30 μL) after a single blink, therefore simulating an in vivo 
scenario.34  
 
Single dose: the eyes were dosed with a single 10 µL aliquot of 0.2 or 2.0 chlorhexidine 
digluconate eye drop or a contact lens soaked in the corresponding solution to determine the 
effect of concentration on delivery. To determine the effect of β-CD addition, eyes were 
dosed once with 10 µL eyedrops of 2.0 % chlorhexidine, 2.0 % chlorhexidine in combination 
with 30 mg/mL β-CD or contact lenses containing 2.0 % chlorhexidine or 2.0 % 
chlorhexidine + 30 mg/mL β-CD. The eyes were left for 2 h, 6 h or overnight (approximately 
24 h), with half the eyes receiving continuous irrigation with STF at a rate of 0.1 mL/min to 
mimic tear 
 
Multiple dose: to simulate current clinical practice in the ocular administration of 
chlorhexidine, porcine eyes were dosed with 10 µL aliquots of 0.2 or 2.0% chlorhexidine 
digluconate at T0 and then at hourly intervals up to a total of 6 hours (7 doses) and all under 
constant STF irrigation (simulated in vivo scenario). At 1 hour after the final dose the corneas 
were excised. As a comparison, contact lenses soaked in chlorhexidine solution were applied 
for the same durations.  
 
2.5 Cornea extraction  
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After the predetermined time, corneas were excised by blunt dissection using a scalpel - 
where contact lenses were used, any residual chlorhexidine was first removed from the ocular 
surface by further irrigation with STF. The excised corneas had a wet-weight of 0.2269 ± 
0.0201g (n=6, ±SD); any that were found to be out of this range were not used. The corneas 
were then cut into small pieces and chlorhexidine extracted by gentle mixing in two 
sequential volumes of methanol for 18-24h each. The methanol from the both extraction steps 
was combined, centrifuged for 15 min and supernatants evaporated at 60 ºC overnight. 
Residues were reconstituted with 1 mL mobile phase and transferred to autosampler vials for 
HPLC analysis. 
 
2.6 High Performance Liquid Chromatography (HPLC) analysis  
Chlorhexidine was determined by HPLC analysis using an Agilent 1100 system comprised of 
a G1379B degasser, G1311A quaternary pump, G1313A ALS autosampler and G1314A 
VWD detector. The separation method employed an isocratic mobile phase of 50:50 v/v 
acetonitrile:5 % aqueous trifluoracetic acid and a Phenomenex Kinetex 5 μm C18 150 x 4.6 
mm column. The detection wavelength was set at 245 nm, injection volume 20 µL and flow 
rate 1.5 mL/min. Under these conditions, chlorhexidine was found to have a retention time of 
approximately 1.2 min. A chlorhexidine calibration curve was constructed in mobile phase 
over the concentrations 1.00 to 7.81 x 10-3 mg/mL. The absence of potential matrix effects a 
calibration curve prepared in aqueous centrifuged and filtered corneal homogenate provided 
the same calibration coefficient. 
  
2.7 NMR and molecular modeling analysis of chlorhexidine-β-cyclodextrin inclusion 
complexation  
NMR spectra were recorded on a Bruker AVANCE 500 spectrometer (500 MHz) and auto-
calibrated to the deuterated solvent reference peak. Chemical shifts are given in  relative to 
tetramethylsilane (TMS); the coupling constants (J) are given in Hertz. TMS was used as an 
internal standard ( = 0) for 1H-NMR and CDCl3 served as an internal standard ( = 77.0) for 
13C-NMR. The chlorhexidine 20% solution in water and chlorhexidine-β-CD samples were 
analyzed suppressing water solvent peak.  
 
2.8 Molecular modeling  
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Computational studies were carried out on a 1.80 GHz Intel Xeon (8 cores) processor-based 
computer, running Ubuntu 14.04 LTS. Preparation of the structure, simulations and analysis 
were carried out with Maestro v 11.4, (Schrödinger LLC, New York, NY, 2017). The 
molecular dynamic (MD) simulations were performed using the Desmond package 
(Schrödinger New York, NY, 2017). The initial chlorhexidine-β-CD complex was manually 
prepared following the structural information reported previously.35 The β-CD complex was 
solvated with TIP3P water such that a water shell 10 Å in thickness was formed around the 
complex, using OPLS3 force field. The solvated complex was then simulated with the NPT 
relax protocol in Desmond. The protocol involved an initial minimization of the solvent with 
restrains on the solute, which was followed by MD simulations of 500 ns in NPT ensembles 
with temperature (300 K) and pressure (1 atm) constant. Data were collected every 100 ps 
(trajectory). Each chlorhexidine-β-CD complex simulation was performed in triplicate, using 
a random seed as a starting point each time. The estimated ΔGbinding was calculated using the 
Desmond command-line script thermal_mmgbsa.py collecting the value every 100 ps and a 
stability constant was determined from a standard phase solubility plot. Then, van der Waals 
volume predictions of chlorhexidine and chlorhexidine-β-CD complex (VvdW) were carried 
out with MOE 2015.10, where the van der Waals volume is defined as the space occupied by 
the molecule, which is impenetrable to other molecules at standard conditions. 
 
2.9 Antimicrobial well diffusion assay  
A modified version of the well diffusion assay was performed to demonstrate that the 
chlorhexidine delivered to corneas was antimicrobially active against E. coli – a model 
organism chosen to demonstrate bacterial keratitis.36 In triplicate, porcine eyes were treated 
as previously described with either a 2.0 % chlorhexidine eyedrop, a 2.0 % chlorhexidine + 
30 mg/mL β-CD eyedrop, a 2.0 % chlorhexidine-soaked contact lens, a 2.0% chlorhexidine + 
30 mg/mL β-CD soaked contact lens, or control eyedrops or contact lenses (deionized water), 
for 6 h with STF irrigation before corneal excision. LB agar was prepared from dry powder 
according to manufacturer’s instructions and poured to a depth of 4 mm in 100 x 15 mm petri 
dishes. E. coli was revived from glycerol stock previously prepared from NCTC-sourced 
ampoule and frozen at -80 °C. A 0.5 MacFarland suspension of E. coli was prepared in PBS 
by adjusting the optical density to 0.1 ± 0.2 AU at 625 nm. Cotton swabs were used to spread 
suspension evenly over the surface of LB agar plates before using a sterile 15 mm diameter 
cork borer to remove a disk of agar from the center, creating a well in each plate. A single 
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excised cornea was placed in each agar well and covered with 300 μL PBS before incubation 
at 37 ºC for 18-24 h. The diameter of the zone of growth inhibition was measured in mm.  
 
2.10 Statistical Analysis  
Statistical analysis was performed using InStat statistical package (GraphPad Software Inc. 
San Diego, CA, USA). ANOVA was performed on all data sets to assess for significant 
differences in corneal chlorhexidine levels between delivery methods and to compare the 




3.1 Single dose: delivery of chlorhexidine to the cornea 
The time course for the amount of chlorhexidine delivered into the cornea was determined at 
2, 6 or 24 h. Eyes were dosed with 2.0 % chlorhexidine eyedrops or 2.0 % soaked contact 
lenses, both with or without the addition of β-CD, and were incubated with or without STF 
irrigation. The highest amount of chlorhexidine was delivered to the cornea from 
chlorhexidine-only contact lenses (blue square) at all time points (p <0.001), with eyedrops 
delivering 0.43 ± 0.6 µg and 5.13 ± 2.1 µg chlorhexidine to the cornea (with and without 
STF, respectively) and the contact lenses delivering over sixty times the amount of 
chlorhexidine with (26.1 ± 6.16 µg) and over seven times without STF (36.25 ± 9.43 µg) 
compared to the eyedrops after 6 h (Figure 3). Addition of β-CD to eyedrops significantly (p 
<0.001) increased the amount of chlorhexidine delivered to the cornea at all time points when 
compared to standard eyedrops, ± STF. For example, at 2 h with STF, only 1.84 ± 0.23 µg 
was delivered with the standard eyedrops but over six times the amount, 11.71 ± 3.0 µg, was 
delivered when β-CD was added. In addition, after 6 h, a low 0.43 ± 0.6 µg chlorhexidine 
remained in the cornea when delivered with the standard eyedrops, but a 19-fold increase in 
chlorhexidine was observed when β-CD was included in the eyedrops without STF.  
Chlorhexidine-loaded contact lenses, however, still delivered significantly (p <0.001) 
more chlorhexidine to the cornea than chlorhexidine-β-CD eyedrops, at all time points with 
and without the addition of STF (Figure 3). However, addition of β-CD to the drug loaded 
contact lenses did not improve chlorhexidine delivery when compared to the chlorhexidine-
only lenses. At all timepoints, with or without the addition of STF, no significant difference 
(p >0.05) in the amount of drug delivered to the cornea was found between standard and β-
   10 
CD contact lenses. In fact, it can be seen that the contact lenses delivered slightly more drug 
at all time intervals without β-CD being added (under the same STF conditions).  
Although not statistically significant, when delivering chlorhexidine from contact 
lenses without STF, an increase in the amount of drug reaching the cornea was indicated 
between 2 and 6 h time points, whereas the amount decreased by 24 h (Figure 3). When 
irrigated with STF, there was also an increase in chlorhexidine delivered to the cornea 
between 2 and 6 h from the contact lenses, but less so than without STF, and this likewise 
decreased after 24 h. 
The chlorhexidine-β-CD contact lenses applied to eyes not receiving STF also 
produced a significant (p <0.01) increase in corneal chlorhexidine from 2 to 6 h, then a 
decrease in drug delivered at 24 h. With the addition of STF, this effect was negligible with 
the levels of chlorhexidine remaining fairly similar throughout the time intervals. While the 
amount of chlorhexidine delivered from eyedrops did not change as markedly over time as 
with contact lenses, a small but insignificant increase in the amount delivered between 2 and 
6 h was observed without STF whereas with STF the amount of chlorhexidine delivered to 
the cornea decreased over time. These data demonstrate the effect of STF on quantification of 
ocular drug delivery. Constant ocular irrigation clearly reduces the amount of chlorhexidine 
absorbed into the cornea in every delivery scenario, the greatest difference being observed 
with the β-CD contact lenses at 6 h (Figure 3). 
 
3.2 Multiple 1h doses of eyedrops vs contact lenses, with STF irrigation 
Table 1 shows the amount of chlorhexidine localised in porcine corneas as a function of 
dosing frequency (hourly), with extraction of corneas 1 hour after final dose. The 
experiments were conducted under constant irrigation with STF to simulate in vivo 
conditions. Two drug concentrations were used, 2% and 0.2% - the latter was intended to 
simulate a typical regimen currently used to treat fungal keratitis.   
When dosed with 0.2%, the chlorhexidine reached steady state after 5 hours following 
the instillation of 4 x 10 µL drops. Steady state was attained at a dose of ~1 µg. By 
comparison, the chlorhexidine level continued to rise over the duration of the experiment, 
when contact lenses loaded with 0.2% chlorhexidine were used. After 7 hours, the 0.2% drop 
provided 1.01 ± 0.25 µg chlorhexidine, whereas the lens provided 10-fold this amount at 10.9 
± 0.61 µg (p <0.05).  The total amount of chlorhexidine dosed over the course of this 
experiment was 120 µg.  
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When dosed with 2% chlorhexidine drops, steady state was achieved after 4 hours (3 
x 10 µL drops), at a level of ~6 µg. This is 6x more that achieved from 0.2% drops (p <0.05). 
Using 2% loaded contact lenses the concentration seemed to reach steady state after 6 hours, 
at a level of approximately 26 µg per cornea. This was ~4.2 x the level obtained with 2% 
chlorhexidine drops (p <0.05). Furthermore, the value of 26 µg matches very closely the 
value of 26 µg obtained in 3.1 for the single dose at 6 hours. The total amount of 
chlorhexidine dosed onto the eyes was 1200 µg. 
 
3.3 NMR & molecular modelling  
NMR analysis was performed in order to examine the formation of chlorhexidine-β-CD 
complexation. The chlorhexidine spectrum showed two broad doublets in the aromatic region 
(δ 7.0 and 6.9 ppm), and three peaks for the protons in the aliphatic biguanide internal chain 
(δ 2.82, 1.12 and 0.89 ppm). The comparison between chlorhexidine and chlorhexidine-β-CD 
clearly showed a change in the aromatic protons H8, H7, H11 and H12 (Figure 4) of the 
phenyl moiety, that are slightly deshielded in the chlorhexidine-β-CD complex (δ 7.28 and 
7.13 ppm, δ of +0.2 ppm). This de-shielding effect suggests the proximity of electronegative 
atoms (e.g. oxygens of cyclodextrin) to the aromatic protons, and this change in electron 
density increased the chemical shift of the aromatic protons. These observations might 
indicate that chlorhexidine aromatic rings are inserted in the β-CD cavity and are consistent 
with those described in the literature.37,38 Molecular modelling studies were conducted to 
further interpret the NMR data. As shown in these earlier papers, which included Job’s plot 
analysis, a 1:2 ratio complex of chlorhexidine to β-CD was also found possible in this 
simulation, with the inclusion of the aromatic rings of the drug in the less polar but more 
lipophilic central cavity of the β-CD. This inclusion complexation is stabilized through van 
der Waals and hydrophobic forces. Figure 5 shows space-filling depictions of chlorhexidine 
and chlorhexidine-β-CD inclusion complex involving two β-CD molecules, allowing the 
comparison of molecular volumes of 477.13 Å3/molecule and 2283.12 Å3/complex 
respectively. 
In order to better understand the inclusion of chlorhexidine in β-CD, a series of 500 ns 
dynamics simulations were performed evaluating the change in van der Waals energy in the 
system composed by chlorhexidine and two β-CD molecules. The variations of van der 
Waals energy during such dynamic simulations can be considered a significant parameter in 
the prediction of host-guest inclusion complex stability, with high energy indicating a less 
favorable – and therefore less probable – conformation. In the current investigation, the 
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position and orientation of the guest molecule with respect to the host was mainly 
perpendicular with the two mono-chlorophenyl rings inside the cavity. While this 
arrangement showed the lowest energy during the entire MD simulation (Figure 6), the 
complex was not static, but rather continuously forming and dissociating during the 
simulation. This observation was supported by the binding free energy calculations, 
confirming that the van der Waals interaction was the key force in forming the complexes, 
and moreover showing the high binding affinity of chlorhexidine in complex with β-CD at a 
1:2 ratio (ΔG average -53.56 ± Standard Deviation 27.50) as shown in Figure 7. The 
difference in binding energy (ΔG Range: -87.67 to 1.24) can explain the desolvation process 
and release of chlorhexidine from the β-CD carrier system. This is supported by a relatively 
low stability constant (Kc) of value (201.92 M-1) as determined using the Higuchi & Connors 
(1965)39 approach (data not shown) which is probably due to the presence of the 2 positive 
charges.40 Lying within the range 100–1000 M-1, this value suggests that the chlorhexidine–
HP-β-cyclodextrin complex is sufficiently stable within the aqueous solution, yet the 
interaction between drug and carrier is weak allowing dissociation41, as indicated in Figure 7, 
allowing the drug to penetrate the cornea. 
In summary, in silico modelling showed that masking the lipophilic aromatic rings of 
chlorhexidine inside the β-CD molecules could allow the chlorhexidine molecule to approach 
the corneal epithelium more effectively, and dissociation/release thereafter making 
chlorhexidine available to penetrate into the cornea. 
 
3.4 Contact lenses 
A mean of 794.3 ± 37.05 µg chlorhexidine was loaded into the chlorhexidine-loaded lenses, 
whilst 773.9 ± 97.3 µg chlorhexidine was loaded into the chlorhexidine-β-CD lenses. There 
was no significant difference between chlorhexidine loading with and without β-CD 
(p>0.05). Contact lenses containing chlorhexidine only delivered a higher percentage of their 
initial dose to the cornea compared to the chlorhexidine eyedrops at all time points (p 
<0.001), with 2.39 ± 0.9 % delivered at 2 h, 4.32 ± 1.2%, at 6 h and 1.44 ± 0.01% after 24 h. 
Addition of β-CD, in accordance with the previous findings, did not increase the percentage 
of drug delivered from the initial dose in the contact lenses. Unlike the chlorhexidine and 
chlorhexidine-β-CD eyedrops, equal percentages were delivered after 2 h (2.39%), and 
significantly less (p <0.001) was delivered after 6 and 24 h from the β-CD contact lens (1.87 
± 0.69 % and 1.18 ± 0.71 %, respectively).  
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These figures are low compared to previous research, for example, it was reported 
that at least 20% of the timolol entrapped within their soft gel contact lens entered the cornea, 
which was much larger than the fractional uptake for drug delivery through eyedrops.22 
However, different chemistries in terms of both lens polymer and loaded drugs make 
extrapolations and comparisons to other systems unrealistic. 
 
3.5 Antimicrobial diffusion assay  
With a reported chlorhexidine minimum inhibitory concentration (MIC) of 4 μg/mL42 E. coli 
NCTC 10418 was selected as a susceptible model organism to confirm delivery of active 
drug to porcine corneas after 6 h. The zones of inhibition produced by corneas treated with 
chlorhexidine eyedrops and contact lenses with and without β-CD can be seen in Figure 8 and 
Table 2. 
Corneas treated with contact lenses containing only chlorhexidine exhibited the 
largest zone of inhibition of all conditions tested (30.3 ± 1.0 mm), whilst chlorhexidine-only 
eyedrops delivered the least active drug to corneas, producing the smallest observed zone of 
inhibition of 18.3 ± 2.9 mm (note: this included the diameter of the well which was 15 mm). 
When treated using chlorhexidine-β-CD contact lenses, wells containing the excised cornea 
produced a zone of inhibition of 27.8 ± 0.8 mm compared to 30.3 ± 1.0 mm with the 
chlorhexidine-only contact lenses, as seen in Figure 7. Although this difference was not 
statistically significant (p >0.05), the trend agrees with the previous findings that addition of 
β-CD to the contact lenses did not enhance chlorhexidine delivery but possibly reduced it 
slightly. Alternatively, less chlorhexidine was loaded into the chlorhexidine-β-CD contact 
lenses – the reduced effectiveness of such lenses may simply reflect this. However, there was 
no significant difference between the amounts of chlorhexidine loaded into the contact lenses 
so this cannot be assumed.  
The increase in chlorhexidine delivered from eye drops when combined with β-CD 
was reflected in the observed zones of inhibition with corneas receiving the chlorhexidine-β-
CD eyedrops which produced a larger zone of inhibition than chlorhexidine-only eyedrops 
(20.3 ± 1.9 mm and 18.3 ± 2.9 mm, respectively). Although the difference between 
treatments was not statistically significantly, the zone produced by chlorhexidine-β-CD 
eyedrop treated corneas was significantly larger (p <0.01) than that produced by those given 
control eyedrops treatment (0 mm), whilst chlorhexidine-only eyedrops failed to deliver 
enough to the cornea to create a large enough zone of inhibition to be statistically different 
from the control (p > 0.05).  
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By way of bridging the amount of drug delivered to the cornea from the various 
formulations with the observed microbiological effect, a plot of drug mass per cornea (μg) 





Topical ocular therapies delivered in the form of eyedrops generally have poor availability 
due to blinking, tear production and nasolacrimal drainage, meaning up to 95 % of the drug 
in the applied dose is lost due to lacrimal washing or absorption through the conjunctiva.5,22 
In the case of using chlorhexidine to treat keratitis, the eyedrop regimen is intensive, as 
explained. Moreover, it is commonplace for a patient to need to strictly apply eyedrops 
frequently for several weeks in order to maintain therapeutic corneal concentrations and 
allow the infection to clear. This can result in poor patient compliance and discontinuation of 
treatment, ultimately failing to resolve the infection.21 In an attempt to address these issues, 
we investigated an alternative delivery method including β-CD and drug loaded hydrogel 
contact lenses for the enhanced corneal delivery of chlorhexidine. It was further hypothesized 
that these two parameters may also be used cooperatively to achieve even greater rates of 
drug delivery. 
 
4.1 Effect of continual irrigation with STF 
A significant finding from this study was the marked effect of a simple electrolyte-based STF 
on the delivery of chlorhexidine to the cornea in vitro: irrespective of the delivery method 
STF consistently reduced the amount of drug delivered. A symptom of keratitis patients is an 
increased rate of tear production. Although many other chemicals are present, tears are 
almost entirely comprised of water. In the current work we were interested primarily in the 
dilution/washing away effects of tear fluid, hence a simple electrolyte-based STF was used 
based upon a previously reported method.33 
Simulating in vivo conditions, STF would wash away and dilute the applied 
chlorhexidine before it can be fully absorbed through the corneal surface. This would be 
compounded by corneal reflex or blink reflex which would act to eliminate the liquid dose 
from the corneal surface, the greater the number of reflex blinks the greater the amount of 
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drug washed away. The volume of the ‘drop’ delivered to the eye is also important; a larger 
drop would be expected to deliver more drug, but at the same time could elicit more reflex 
blinking. Nevertheless, findings highlight the potential overestimation errors that may occur 
in static in vitro corneal penetration experiments. In addition to washing away drug, the tear 
film presents an additional diffusional barrier which becomes more important with increasing 
drug lipophilicity.43 Chlorhexidine in its charged form is very polar and therefore likely to be 
washed away relatively readily, and perhaps even leached back out of the epithelium. The 
chlorhexidine delivery profiles in Figure 3 illustrate that application of STF prevented drug 
build up in the cornea due to wash out and/or leaching. This is particularly apparent when 
comparing the effect of STF on chlorhexidine delivered per cornea by eyedrops both with 
(CD) and without (D) β-CD. Lack of build-up while using STF indicates that the 
concentration gradient and driving force are weak and serves to highlight wash-out effects 
likely to be seen in vivo. 
Under normal conditions human tear flow is ~ 2 μL/min, with an estimated residual 
volume of 7 μL,19 although tear production rate is significantly elevated during corneal 
infection.44,45 In our irrigation model, the STF was delivered at a rate ~100 μL/min, which 
approximates to a keratitis scenario. Although physiological tears are complex in nature, 43 
the electrolyte-only STF version used here represents a reasonable model in terms of 
mimicking and estimating the effect of hydrodynamic drug wash-out. Therefore, it can be 
hypothesised that the ability of contact lenses to deliver elevated amounts of drug is due, not 
only to the reservoir capacity within the lens matrix, but also to a protective effect conferred 
by the lens which acts to shield the underlying dose from wash out, especially at the lens-eye 
interface. 
 
4.2 Drug delivery to the eye – kinetic considerations 
Drug delivery to the cornea is a dynamic process, governed by a sequence of release and 
partitioning events.46 Firstly, drug must be released from its vehicle, involving dissociation 
from cyclodextrin or dissociation from cyclodextrin and the matrix of the hydrogel contact 
lens. Next, the drug must traverse the tear film followed by the mucus layer overlying the 
corneal epithelium. The drug must then penetrate the tight junctions that exist between cells 
of the epithelium, before finally entering the target tissue – the stroma. However, the stroma 
is not the diffusional sink as the drug can diffuse across the endothelium before entering the 
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anterior chamber and deeper into the eye. Thus, when a drug dose applied to the cornea is 
absorbed, the concentration in the stroma will build up to a level depending on the driving 
force of the concentration gradient. Steady state may be obtained when the amount of drug 
entering the tissue is balanced by the amount exiting, i.e. entering the anterior chamber; 
otherwise the level reduces as the drug continues diffusing into the anterior chamber as 
indicated in Figure 3. 
Table 1 shows that in the multiple dosing experiment, chlorhexidine reached steady 
state after 5 drops (6 hours) attaining a corneal dose of just over 1 µg when dosed with 0.2%. 
This was approximately 1% of the total applied dose, and the % delivered decreased 
thereafter. When dosed with 2%, the chlorhexidine did not quite attain steady state within the 
maximum timeframe of the experiment (7 hours), although levels were clearly much higher 
than 0.2% by a factor of approximately x10; % delivered was approximately 0.75%. Data 
obtained using either 0.2% and 2% highlights the large amount of chlorhexidine that fails to 
penetrate the cornea – this is clearly exacerbated by the STF irrigation, designed to simulate 
high levels of tear production seen in keratitis patients. This is investigated further below. 
When a single dose was applied, steady state cannot be attained. As the applied dose 
depletes, the driving force diminishes and the drug partitions into the anterior chamber, 
causing the resident drug in the stoma to decrease. Here, chlorhexidine resident in the cornea 
was determined at three timepoints (2, 6 and 24 h) following the application of single doses. 
Figure 3 shows chlorhexidine build up and depletion is apparent in most of the chlorhexidine 
delivery profiles. However, the level to which chlorhexidine built up, and subsequently 
diminished varied greatly depending on the manner in which it was applied, and whether or 
not there was constant irrigation with STF.  
Vontobel et al (2015) demonstrated that chlorhexidine (or polyhexamethylene 
biguanide) did not readily permeate from 0.02% solution through the cornea to the anterior 
chamber through excised rabbit corneas, which may explain why treatment of Acanthamoeba 
keratitis requires many months of sustained topical drug administration.9 However, Figure 3 
shows this not to be the case at the higher levels of 0.2 and 2%. 
 
4.3 Effect of β-CD on delivery of chlorhexidine 
It is clear that delivery of chlorhexidine via 0.2 and 2 % eyedrops was poor with no major 
accumulation in the cornea evident. Addition of β-CD clearly enhanced drug delivery 
compared to eyedrops (by a factor of x5 after 2 hours). However, although higher 
concentrations remained after 6 h compared to standard eyedrops, depletion of chlorhexidine 
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from the cornea during STF irrigation still occurred. The efficacy of cyclodextrins in 
enhancing corneal drug penetration is typically attributed to an increase in solubilised 
concentration, thereby creating a higher concentration gradient and driving force. However, 
this logic does not apply to the current data in the same manner, as the chlorhexidine as 
digluconate salt is freely soluble in water.  
The formation of 1:2 chlorhexidine:β-CD host complexes (Figure 6) was confirmed 
by the molecular modelling work as previously reported by Denadai et al (2007). 38 As a 
digluconate salt, chlorhexidine is a symmetrical molecule consisting of a central 
hexamethylene bridge connecting two chlorophenyl and protonated biguanidine groups. As 
depicted in Figure 6c) and d) (circled in red), the chlorhexidine forms a stable complex with 
the two β-CD molecules, inserting the two hydrophobic terminal mono-chloro phenyl group 
inside the β-CD cavities, whereas the central moiety of chlorhexidine bearing 2 x positive 
charges remains uncomplexed. However, the interactions are not particularly strong and the 
modelling simulation showed that the complex readily dissociates. 
It is generally accepted that drug-cyclodextrin complexes cannot penetrate the corneal 
epithelium as a whole unit. However, there is evidence that cyclodextrins interact with the 
surface of the eye specifically by extracting cholesterol from the corneal epithelium, 
disrupting its integrity and rendering it more permeable.47 The sequestration of epithelium 
cholesterol from the cornea has been reported using a 30 mg/mL β-CD solution, resulting in 
significant enhancement of the ocular delivery of riboflavin.19 This may explain why β-CD 
enhanced delivery of chlorhexidine with the eyedrops, as the β-CD molecules are free in 
solution and can act on the corneal epithelium. Using alternative cyclodextrins may produce 
better results: for example, the smaller α-CD which may be less sterically restrained. 
Conversely, cyclodextrin derivatives such as hydroxypropyl-β-CD are likely to experience 
greater steric hindrance and lower levels of drug delivery enhancement. 
 
4.4 Effect of loaded contact lenses on delivery of chlorhexidine 
The effectiveness of contact lens delivery compared to eyedrops was clearly demonstrated in 
this work. There are several advantages of contact lenses over eyedrops in ocular drug 
delivery, including 1) protection from drug washout by tears 2) reduced frequency of dosing, 
with potential 0-order delivery 2) retention of high drug concentrations at the corneal surface, 
enabling the controlled and extended release of the drug, obviating nasolachrymal drainage 
(however, flux was not determined, as the cornea is not the ultimate sink and we were 
interested in the drug concentration resident within the cornea, hence potential activity 
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against microbial infiltrates). The latter is clearly demonstrated in this work with an increase 
in corneal chlorhexidine between 2 and 6 h of contact lens wear, even with constant STF 
irrigation. In comparison, the amount of chlorhexidine delivered between these time intervals 
with eye drops decreased when irrigated with STF due to the washout effect on the applied 
eyedrops.  
As expected, drug-loaded hydrogel contact lenses delivered a significantly greater 
amount of chlorhexidine to the cornea than eyedrops and this was reflected in the significant 
increase in the size of the zones of inhibition produced by treated, excised corneas. The 
contact lenses should not make physical contact with the cornea, rather, the two are separated 
by a thin tear film.48 As chlorhexidine is in the polar cationic charged state, the aqueous tear 
film presents no diffusional barrier between the lens and the corneal surface. This allows for 
increased ocular residence time of the drug and making the chlorhexidine far less susceptible 
to nasolacrimal drainage. At a concentration of 2.0 %, and to a lesser extent 0.2%, 
chlorhexidine provided high levels of delivery from contact lens delivery. Chlorhexidine (as 
digluconate) bears two positive charges and binds to not only microbes, but also membrane 
components including surface mucous, however, by extracting the entire cornea it was not 
possible to differentiate between drug bound to the ocular surface and that that had penetrated 
deeper into the stroma. 
In the current work, the lenses were loaded by immersion in drug solution. Although 
straightforward, the process is reported to have drawbacks such as low capacity and burst 
release.49 However, while the presented data show a prompt high concentration of 
chlorhexidine in the stroma – which is beneficial in providing rapid microbicidal action – 
sustained release over the 24-hour study period was also observed, even with constant STF 
irrigation. Further controlled retardation of the release of chlorhexidine from contact lenses 
may be achieved by several methods such as altering the hydrophilicity of the lens monomers 
49 or the inclusion of other compounds, for example, vitamin E 50 or hyaluronic acid.51 
However, it would not be appropriate to seek to extend the use of contact lenses beyond the 
24 hours used in this study, particularly given that improper/extended use of contact lenses 
may have been responsible for giving rise to the patient’s condition in the first place. 
Replacing the drug-loaded contact lenses on a daily basis is regarded as good practice.52  
As is typical in reservoir-type drug delivery devices (including transdermal patches), 
the dose delivered as a percentage of that loaded into the lens was low. For example, ~4 % of 
the loaded drug was delivered after 6 h of wear (with STF), highlighting that 2.0 % 
chlorhexidine contact lenses are currently a rather inefficient delivery method as the majority 
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of the drug is wasted, trapped inside the contact lens reservoir and not being released.53 
However, the increased amount of drug delivered may make its use clinically relevant, 
perhaps in delivering a high concentration for a shorter time. 
 
4.5 Effect of β-CD and loaded contact lenses on delivery of chlorhexidine 
Our hypothesis that chlorhexidine delivery to the cornea would be enhanced using a 
combination of both β-CD complexation and hydrogel contact lenses was not supported. 
Combinations of techniques have previously yielded success in ocular drug delivery,54 and β-
CD has previously been shown to facilitate the controlled release of chlorhexidine from 
polymer matrices.29 However, no significant difference between the delivery of chlorhexidine 
from chlorhexidine-only loaded lenses and chlorhexidine-β-CD lenses was found, as shown 
with the in vitro ocular delivery experiment. In fact, chlorhexidine-β-CD contact lenses 
delivered somewhat less than the chlorhexidine-only contact lenses. This was supported by 
the statistically similar zones of inhibition produced by contact lens-treated corneas (Figure 
8). 
From Figure 6 it was determined that the volume of the complex was ~5x that of 
chlorhexidine.  This would sterically restrict its ability to dissociate and liberate 
chlorhexidine within the hydrogel polymer matrix, and therefore release at the eye surface, as 
depicted in Figure 10. Consequently, there would be a reduced apparent concentration 
gradient than that achieved with chlorhexidine-only loaded lenses and thus less drug would 
be able to diffuse out of the contact lens and into the eye. This process could be coupled with 
less cholesterol sequestration by the free β-CD molecules. However, at 6 hours the β-CD 
chlorhexidine contact lens delivery results were similar to the chlorhexidine-only lenses, 
although after 24 hours, the amount of chlorhexidine delivered from β-CD containing lenses 
was significantly less than from those without β-CD, perhaps indicating the comparative 
steric trapping of complexed drug within the lens. 
Whether or not the epithelium is ulcerated is significant regarding topical antibiotic 
penetration into the corneal stroma. Generally, topically applied compounds poorly penetrate 
the cornea when the epithelium is intact, although if ulceration has occurred the epithelium is 
evidently no longer a barrier.5 Indeed debridement of the corneal epithelium is practiced in 
some clinics to enhance the penetration of antimicrobials to the stroma. 
 
4.6 Potential clinical relevance – microbiology 
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The correlation between chlorohexidine concentration in the cornea and zone of inhibition 
data (Figure 9) provided validation of the different capabilities of the various drug delivery 
approaches evaluated.  
The reported MIC90 of chlorhexidine for Aspergillus spp. and Fusarium spp., the most 
common fungi associated with fungal keratitis, are 8.6-16 µg/mL and 2-8 µg/mL, 
respectively,55 while the MIC for Acanthamoeba is approximately 6.25 µg/mL.56 We can 
estimate whether sufficient chlorhexidine to inhibit microbial growth has been delivered to 
the cornea by using the corneal volume to deduce the local concentration. The volume of a 
standard porcine cornea has been previously determined as 0.190 mL/cornea57. This value 
was used in the equation below to determine the local chlorhexidine concentration values: 
𝐶𝑜𝑛𝑐 (
µ𝑔





Based on this, delivery by singly dosed eyedrops was unsurprisingly poor and chlorhexidine 
levels would not attain the MICs against any of the above microorganisms beyond the 2 h 
time point, suggesting that they would need to be dosed frequently in order to achieve 
consistent therapeutic concentrations in the cornea. Based on the values in Figure 3, with STF 
irrigation eyedrops without β-CD produced a local chlorhexidine concentration of 9.5 µg/mL 
(1.8 µg/cornea) 2 h after exposure but this reduced to 2.3 µg/mL (0.43 µg/cornea) at 6 h. 
Chlorhexidine eyedrops containing β-CD showed an improvement over those without, 
delivering and maintaining chlorhexidine concentrations of 61.6 µg/mL (11.71 µg/cornea), 
42.8 µg/mL (8.13 µg/cornea) and 27.0 µg/mL (5.13 µg/cornea) at 2, 6 and 24 h, respectively, 
indicating their superiority to chlorhexidine-only eyedrops and suggesting that such eyedrops 
may not need to be dosed as frequently in order to maintain therapeutic concentrations in 
vivo. However, chlorhexidine loaded contact lenses delivered drug concentrations far 
surpassing the MICs for Aspergillus spp., Fusarium spp. and Acanthamoeba, both with and 
without β-CD, demonstrating the superiority of contact lenses for delivering chlorhexidine to 
a clinically beneficial level compared to delivery from eyedrops. Even after 24 h with the 
poorer performing β-CD containing contact lens, 53.7 µg/mL (10.21 µg/cornea) 
chlorhexidine was present in the corneas – over 3 times the MIC for the least susceptible 
microorganism considered. 
4.5 Potential clinical relevance – cytotoxicity 
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Chlorhexidine is known to be cytotoxic; however, it continues to be widely used in, for 
example, personal care products for the buccal cavity. Typically, 0.02% - 0.2% chlorhexidine 
solutions are used in ocular therapeutics.58 Vontobel et al (2015) reported no toxicity to or 
disruption of the barrier function of the corneal epithelium from a 0.02% solution.9 Ocampo 
(2005) reported that no severe inflammation and structural alterations in the deep layers of 
the cornea in rabbit eyes when dosed with multiple applications of 0.2% chlorhexidine 
gluconate as a pure solution; although this contradicted an earlier report where toxicity was 
noted.59,60 Anecdotal reports from field trials indicate that the use of 0.2% chlorhexidine 
drops for treating fungal keratitis is tolerated, with a few incidences of initial stinging and 
mild surface toxicity - which resolves and is much milder than that seen with some other eye 
drops, such as fortified gentamicin - also used in severe ocular infections (Burton, personal 
communication). Tabor et al, (1989) and Bever et al (2016) both reported that 4 % solution 
were toxic and caused opacification of the cornea.61,62 Intravitreal injection of aqueous 0.1% 
chlorhexidine was associated with a low rate of post-injection endophthalmitis and was well 
tolerated by patients.63 Together these reports indicate a concentration dependence to ocular 
toxicity although they do not provide information as to the levels of chlorhexidine delivered 
to the cornea, which will be formulation-dependent. Interestingly, Teixeira et al (2015) 
reported that α-CD, β-CD and HP-β-CD increased the antimicrobial activity of chlorhexidine, 
but decreased its cytotoxic effects on mammalian fibroblasts and osteoblasts. 64 
Some Acanthamoeba and fungal keratitis infections are considered untreatable with 
current drug therapies, including 0.02% to 0.06% chlorhexidine eyedrops. Therefore, higher 
concentrations of chlorhexidine may be justified since the risk of vision loss in these cases is 
very high. 65, 66 A carefully monitored dose from a lens containing 2 % chlorhexidine could 
be justifiable, where the greater drug penetration would allow it to target deeply embedded 
infiltrates. However, this would need to be considered against the elevated risk of toxicity. 66 
 
5. Conclusion 
Addition of β-CD to chlorhexidine eyedrops enhanced drug delivery to the cornea relative to 
control; however, drug loaded contact lenses alone proved much superior and delivered 
concentrations surpassing the MIC against causative fungi involved in keratitis throughout 
the 24-hour study period. The β-CD eyedrops may have application in corneal ulceration, 
whereas the loaded lens would be more applicable for treating non-ulcerated infiltrates. From 
   22 
a methodological standpoint, the use of appropriate STF irrigation should be practiced in 
future in vitro ocular delivery experiments to ensure delivery rates are not over-estimated. 
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Legends to figures 
 
Figure 1. Chemical structures of β-cyclodextrin and chlorhexidine.  
Figure 2. Schematic representation of drug-loaded contact lens in situ, showing a higher 
concentration gradient providing increased drug delivery to the stroma, as described by 
Fick’s laws of diffusion.  
Figure 3.  Time course profiles for the delivery of chlorhexidine into porcine corneas over 24 
h (n=3 ± SD). Key and rank order (highest to lowest at 6h): CL (contact lens) > BCD+CL (β-
cyclodextrin + contact lens) > CL+STF (contact lens + simulated tear fluid irrigation) > CD 
(β-cyclodextrin) > CD+STF (β-cyclodextrin + simulated tear fluid irrigation) > D (eyedrop 
alone) > D+STF (eyedrop + simulated tear fluid irrigation). 
Figure 4. 1H NMR spectra. a) chlorhexidine, b) chlorhexidine-β-CD, c) superimposition of 
the two spectra, (500 MHz, in H2O) and d) a representation of chlorhexidine with both phenyl 
groups located with two β-CD molecules.  
Figure 5. Space-filling representations of chlorhexidine (above) and chlorhexidine inclusion 
complex involving two β-CD molecules.  
 
Figure 6. Chlorhexidine-β-CD molecular dynamic simulations. The graph shows the 
variations of the van der Waals energy related to chlorhexidine during the simulation. The 
four images are the frames representative of the different states of the system during the 
simulation. The images a) and b) (circled in blue), show the position and orientation of 
chlorhexidine in the system when the van der Waals energy is the highest. In this condition, 
the chlorhexidine molecules are dispersed in the water system and distant from β-CD 
complex. In the images c) and d) (circled in red), the chlorhexidine forms a complex with the 
two β-CDs, inserting the two mono-chloro phenyl group inside the β-CD cavities. In this 
conformation the system energy is the lowest, and consequently the most stable condition. 
 
Figure 7. Plot showing the variations of binding free energy (ΔG) of β-CD – chlorhexidine 
inclusion complexation during the simulation. The energy data were collected every 10000 
picoseconds (ps) starting from 250000 ps. The graph clearly shows the ligand binding and 
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releasing mechanism of β-CD – chlorhexidine complex, with a wide variety of binding free 
energy during the desolvation process (ΔG max = 1.24) and binding process (ΔG min = -
87.67). 
 
Figure 8. Zone of inhibition analysis for chlorhexidine released from treated corneas against 
E. coli. In accordance with the amounts of chlorhexidine quantified by HPLC, the zones of 
inhibition produced by corneas treated with contact lenses containing only chlorhexidine 
exhibited the largest zone of inhibition (30.3 ± 1.0 mm) of all conditions tested (Figure 7 a), 
whilst chlorhexidine eyedrops delivered the least active drug to corneas, producing the 
smallest observed zone of inhibition (Figure 7 b) of 18.3 ± 2.9 mm (note: measurements 
included the diameter of the well which was 15 mm). When treated using chlorhexidine-β-
CD contact lenses, wells containing the excised cornea produced a zone of inhibition of 27.8 
± 0.8 mm compared to 30.3 ± 1.0 mm with the chlorhexidine contact lenses, as seen in Figure 
8 c.  
 
Figure 9. Correlation of zone of inhibition versus chlorhexidine delivery to the cornea for the 
different formulations tested. Inhibition zone diameters were converted to area (mm2 = π x 
(mm/2)2) and corrected for the area of the 15 mm diameter well (i.e. inhibition zone area - 
well area). Corrected inhibition zone area = 22.56 x [CHX delivered]. 
 
Figure 10. Schematic representation of cyclodextrin-chlorhexidine inclusion complexes 
loaded into contact lens. Dissociation, or drug release is sterically inhibited at point X due to 
proximity to polymeric matrix. This assists rationalising the unexpectedly reduced corneal 
delivery of chlorhexidine observed when using chlorhexidine-β-CD contact lenses. 
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Fig 2  
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Fig 5 
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 Hourly dosing 10 μL 0.2% 
chlorhexidine digluconate 




Hourly dosing 10 μL 2% 
chlorhexidine digluconate 













μg in cornea @ T+1h 
1 <LOD 20  1.4 ± 0.08 2.3 ± 1.3 200 6.22 ± 0.8 
1,2 0.06 ± 0.02 40  4.4 ± 0.9 2.0 ± 1.2 400 9.28 ± 0.55 
1,2,3 0.21 ± 0.07 60  6.4 ± 0.40 6.03 ± 0.07 600 15.66 ± 1.22 
1,2,3,4 0.89 ± 0.20 80  8.0 ± 0.33 6.4 ± 0.7 800 21.82 ± 2.54 
1,2,3,4,5 0.72 ± 0.11 100  10.1 ± 1.80 5.89 ± 0.78 1000 26.70 ± 3.48 
1,2,3,4,5,6 1.01 ± 0.25 120  10.9 ± 0.61 6.01 ± 1.05 1200 25.08 + 1.22 
 
Table 1 The amount of chlorhexidine localised in porcine corneas as a function of dosing frequency, 1 hour after last dose, at concentrations of 
0.2 and 2% (n=3 ± SD). Simulated tear fluid applied throughout. 






Average Zone of 
Inhibition (mm) 
Chlorhexidine-only contact lens 30.3 ± 1.0 
Chlorhexidine-β-CD contact lens 27.8 ± 0.8 
Control contact lens 0 
Chlorhexidine-only eyedrops 18.3 ± 2.9 
Chlorhexidine-β-CD eyedrops 20.3 ± 1.9 
Control eyedrops 0 
Table 2 Average zone of inhibition (mm) against E. coli from chlorhexidine containing corneas, according to the chlorhexidine delivery method. 
Chlorhexidine was delivered to corneas by either chlorhexidine-only eyedrops, chlorhexidine-β-CD eyedrops, chlorhexidine-only loaded contact 
lens or chlorhexidine-β-CD loaded contact lens while irrigated with STF. Six hours after initiation of treatment, corneas were excised and placed 
in wells for the well diffusion assay. 
 
